RISE OF THE ROBO- ADVISOR: UK LEADERS OVERWHELMINGLY TURNING TO AI FOR BUSINESS MENTORSHIP IN THE ABSENCE OF HUMAN MENTORS
NEWS
SATISFACTION WITH CARE EXPERIENCES MAKES A SIGNIFICANT DIFFERENCE FOR CANCER SURVIVORS, AREA ONCOLOGIST SAYS
ProCure Proton Therapy Centre highlights a vital element in the care journey: the patient experience. Beyond advanced technology, both published research and individual patient stories suggest that attentive, personalised care helps patients feel valued and supported, profoundly impacting their well-being.
“ In the research community, it has long been understood that patients who are more satisfied with their overall care experiences tend to have better outcomes,” stated ProCure Medical Director Brian Chon, M. D.“ Among the publications presenting evidence for this correlation in cancer care are the British Medical Journal and the Patient Experience Journal. That’ s why we have consistently emphasised the importance of an exceptional patient experience alongside proton therapy’ s benefits of precise targeting and minimal side effects, with less radiation exposure to surrounding healthy organs.”
Many of the patient stories featured on ProCure’ s website attest to their success in combining the strengths of advanced technology and personalised care. For example,“ John”, a prostate cancer survivor, tells fellow ProCure patients that“ You’ ve come to the greatest place you can imagine for cancer treatment.”
Dr Chon emphasises that, when observing this impact at a patient-by-patient level, it becomes clear that it stems from boosting patients’ emotional outlook and treatment adherence.
“ Every patient has a unique story,” Dr Chon said.“ Yet among the ProCure patients that we’ re honouring this month, we hear the recurring theme of how much they value the uplifting care experience that we strive daily to deliver.”
RISE OF THE ROBO- ADVISOR: UK LEADERS OVERWHELMINGLY TURNING TO AI FOR BUSINESS MENTORSHIP IN THE ABSENCE OF HUMAN MENTORS
Research from The Adaptavist Group exposes a disconnect between AI reliance and training, as half of UK leaders admit they are not confident in their self-taught AI skills.
Four out of five( 80 %) business leaders have used GenAI as a business mentor at least once, and a quarter( 26 %) use it for mentorship on a daily basis.
The research was based on a poll of 300 business leaders in the UK. It also revealed that a significant 90 % of business leaders believe there is a mentorship gap in the UK, driving swathes to turn to AI for support. However, despite business leaders’ increasing reliance on GenAI tools, the vast majority lack training, and the study uncovers an enormous appetite for greater guidance on leveraging the technology.
The research shows that business leaders are now using AI more frequently than a human for mentorship. In fact, just 16 % turn to a person for business advice on a daily basis, which came in at 10 % less than those who use GenAI. Reflecting on the human element, a third( 32 %) said they had only received human mentorship once or twice in total, and a further 26 % said they had only received such mentorship a handful of times( three or more). Beyond the interpersonal implications of these findings, AI is also having an overwhelmingly positive impact on business success. According to respondents, 59 % said AI has improved operations and 35 % said it has already helped their business to grow. Looking forward, 62 % still see AI as a worthwhile investment and a significant 82 % said it will help them to further accelerate business growth.
www. intelligenthealth. tech 11